If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

15 Jul 2013 17:15

RNS Number : 3688J
Plant Health Care PLC
15 July 2013
 



15 July 2013

 

PLANT HEALTH CARE PLC("Plant Health Care" or the "Company")

 

Director's dealing

 

Plant Health Care (AIM / CISX: PHC.L) announces that it has entered into a binding agreement with Mr John Brady, a director of the Company. Under the agreement, Mr Brady shall exercise, in two equal tranches on 15 October 2013 and 13 November 2013 all of his options over unissued shares in the Company, which equate to 975,000 Plant Health Care shares ("Shares"). On each date Mr Brady shall sell such number of Shares as is sufficient to cover the exercise price and his associated tax liability arising from the exercise. Any sale of Shares shall be at the prevailing market price and subject to sufficient demand in the market. Further details, using the assumptions specified so as to provide working examples, are set out below:

 

15 October 2013

Mr Brady shall exercise 487,500 options at an exercise price of 37p per Share and sell such number of Shares as shall cover the amount of the aggregate exercise price and his associated tax liability. Assuming a prevailing Share price of 78.5p, being the closing Share price on 12 July 2013, the funds required to cover the exercise price and taxes would equate to approximately £261,000 which would require the disposal of approximately 332,485 Shares*.

 

13 November 2013

56,025 options with an exercise price of 71p per Share (provided they are below the then current market price) and sell such number of Shares as shall cover the amount of the aggregate exercise price and his associated tax liability. Assuming a prevailing share price of 78.5p, being the closing share price on 12 July 2013, the funds required to cover the exercise price and taxes would equate to approximately £274,000 which would require the disposal of approximately 349,045 Shares*.

 

 

 

Notes:

1. The closing share price of 78.5p refers to the closing middle market price of a Plant Health Care share on 12 July 2013 as derived from the daily official list of the London Stock Exchange plc.

2. *An exchange rate of £/$1.5118 has been assumed which was derived from data provided on FT.com by WM/Reuters as at 4.00 p.m. London time on 12 July 2013 (being the last practicable dealing date prior to the date of this announcement).

 

For further information please contact:

 

Plant Health Care plc

Dr. Chris Richards

Chairman

Tel: +44 (0)20 7250 1446

Nomura Code Securities

Clare Terlouw / Chris Golden

Tel: +44 (0)20 7776 1200

www.nomuracode.com

Powerscourt

Paul Durman / Sophie Moate

Tel: +44 (0)20 7250 1446

paul.durman@powerscourtgroup.

com

sophie.moate@powerscourtgroup

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFUFIIFDSEIW
Date   Source Headline
29th Nov 201312:12 pmRNSDirector's Shareholding
25th Nov 20133:15 pmRNSDivestment of non-core subsidiary
18th Oct 20135:00 pmRNSTR-1 Notification of Major Interest in Shares
30th Sep 20135:00 pmRNSTotal Voting Rights
23rd Sep 201310:30 amRNSDirector/PDMR Shareholding
19th Sep 20137:00 amRNSAppointment of Adviser
18th Sep 20133:15 pmRNSDirector/PDMR Shareholding
16th Sep 20137:03 amRNSDirectorate Change
16th Sep 20137:00 amRNSHalf Yearly Report
19th Aug 20132:30 pmRNSBlocklisting Interim Review
30th Jul 20137:01 amRNSUpdate on Harpin
30th Jul 20137:00 amRNSPHC announces plans for Harpin seed treatment
22nd Jul 201311:00 amRNSPHC hires Glen Donald as VP Business Development
19th Jul 20137:00 amRNSHead Office Relocation,Research Facility Expansion
15th Jul 20135:15 pmRNSDirector/PDMR Shareholding
5th Jul 20137:00 amRNSUpdate on CISX Listing
3rd Jul 20137:00 amRNSNew Long-Term Incentive Plan and Grant of Awards
7th Jun 20134:15 pmRNSDirectorate Change
31st May 201311:30 amRNSTotal Voting Rights
21st May 201312:00 pmRNSHarpin Granted Federal Registration in Mexico
10th May 20134:45 pmRNSDirector/PDMR Shareholding
9th May 20131:20 pmRNSDirectorate Change
9th May 20131:20 pmRNSResult of AGM
7th May 201310:00 amRNSDirector/PDMR Shareholding
3rd May 20137:00 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSDirector/PDMR Shareholding
1st May 20137:00 amRNSTotal Voting Rights
25th Apr 20137:00 amRNSPHC and Arysta LifeScience sign license agreement
19th Apr 20133:30 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:33 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:31 pmRNSTR-1 Notification of Major Interest in Shares
18th Apr 20133:31 pmRNSTR-1 Notification of Major Interest in Shares
16th Apr 20138:23 amRNSRe. Investment
15th Apr 20131:30 pmRNSResult of General Meeting
8th Apr 20135:45 pmRNSPublication of Annual Report and Notice of AGM
2nd Apr 20137:00 amRNSConfirmation of Board Changes
27th Mar 20137:00 amRNSPosting of Circular to Shareholders
26th Mar 20134:19 pmRNSBoard Changes
26th Mar 20134:19 pmRNSPlacing and Subscription
26th Mar 20134:18 pmRNSFinal Results
20th Mar 201311:35 amRNSPHC reaches milestone agreement with Germains
11th Mar 20137:00 amRNSMarket Update
19th Feb 20135:45 pmRNSBlock Listing Six-Monthly Return
24th Jan 20139:30 amRNSHarpin field trials results
18th Jan 20135:00 pmRNSNotification of Major Interest in Shares
10th Jan 201312:45 pmRNSTrading Update
31st Dec 201212:25 pmRNSTotal Voting Rights
30th Nov 201211:45 amRNSTotal Voting Rights
2nd Nov 201212:15 pmRNSNotification of Major Interest in Shares
23rd Oct 20127:00 amRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.